The Journal of Experimental Medicine · 2018 · 257 citations · 39 references
Life SciencesMicrobiologyPharmacologyAntimicrobial ResistanceMedical MicrobiologyMicrobial PathogenesisAntibacterial ResistanceAntibiotic ResistanceAntimicrobial TherapyGut MicrobiotaMicrobiome TherapeuticsTargeted Antimicrobial TherapyAntibiotic-resistant Pathogen ControlIntestinal Flora-mediated InteractionsIntestinal Microbiota Modulation
Klebsiella pneumoniae, Escherichia coli, and other members of the Enterobacteriaceae family are common human pathogens that have acquired broad antibiotic resistance, rendering infection by some strains virtually untreatable. Enterobacteriaceae are intestinal residents, but generally represent <1% of the adult colonic microbiota. Antibiotic-mediated destruction of the microbiota enables Enterobacteriaceae to expand to high densities in the colon, markedly increasing the risk of bloodstream invasion, sepsis, and death. Here, we demonstrate that an antibiotic-naive microbiota suppresses growth of antibiotic-resistant clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis by acidifying the proximal colon and triggering short chain fatty acid (SCFA)–mediated intracellular acidification. High concentrations of SCFAs and the acidic environment counter the competitive edge that O2 and NO3 respiration confer upon Enterobacteriaceae during expansion. Reestablishment of a microbiota that produces SCFAs enhances clearance of Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis from the intestinal lumen and represents a potential therapeutic approach to enhance clearance of antibiotic-resistant pathogens.
39
UPARSE: highly accurate OTU sequences from microbial amplicon reads
R. C. Edgar · Nature Methods · 2013 · 17.3K citations
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower, J. Fah Sathirapongsasuti, Nicola Segata et al. · Nature · 2012 · 11.9K citations · Full text
Life Sciences, Biology, Microbiology +17